Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the protein kinase C inhibitor ruboxistaurin. (2022)

First Author: Dowey R
Attributed to:  Optimising Innate Host Defence to Combat Antimicrobial Resistance funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/23120541.00596-2021

PubMed Identifier: 35382002

Publication URI: http://europepmc.org/abstract/MED/35382002

Type: Journal Article/Review

Volume: 8

Parent Publication: ERJ open research

Issue: 2

ISSN: 2312-0541